High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients

Journal of Surgical Oncology

Volumn 105, Issue 3, 2012, Pages 288-292

  Chao, Yin Kai ^a   Chuang, Wen Yu ^a   Yeh, Chi Ju ^a   Chang, Yu Sun ^a   Wu, Yi Cheng ^a   Kuo, Shao Yun ^a   Hsieh, Ming Ju ^a   Hsueh, Chuen ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

chemoradiotherapy; esophageal squamous cell carcinoma; locoregional recurrence; phosphorylated 4E BP1; survival

Indexed keywords

CISPLATIN; FLUOROURACIL; INITIATION FACTOR 4E BINDING PROTEIN 1;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HAZARD RATIO; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; SURVIVAL RATE; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PHOSPHOPROTEINS; PHOSPHORYLATION; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84856301897     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22097     Document Type: Article

References (21)

1. Gebski V, Burmeister B, Smithers BM, et al.: Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis. Lancet Oncol 2007; 8: 226-234. (Pubitemid 46291702)
2. Berger AC, Farma J, Scott WJ, et al.: Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 2005; 23: 4330-4337. (Pubitemid 46207006)
3. Rohatgi P, Swisher SG, Correa AM, et al.: Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 2005; 104: 2365-2372. (Pubitemid 41691557)
4. Rohatgi PR, Swisher SG, Correa AM, et al.: Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 2005; 104: 1349-1355. (Pubitemid 41356149)
5. Rizk NP, Venkatraman E, Bains MS, et al.: American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol 2007; 25: 507-512. (Pubitemid 350002956)
6. Edge SB, Byrd DR, Compton CC, et al.: AJCC cancer staging manual. 7th edition. New York, NY: Spring-Verlag; 2010.
7. Futreal PA, Coin L, Marshall M, et al.: A census of human cancer genes. Nat Rev Cancer 2004; 4: 177-183. (Pubitemid 38337497)
8. Armengol G, Rojo F, Castellvi J, et al.: 4E-binding protein 1: A key molecular "funnel factor" in human cancer with clinical implications. Cancer Res 2007; 67: 7551-7555. (Pubitemid 47281345)
9. Yeh CJ, Chuang WY, Chao YK, et al.: High expression of phosphorylated 4E-binding protein 1 is an adverse prognostic factor in esophageal squamous cell carcinoma. Virchows Arch 2011; 458: 171-178.
10. O'Reilly KE, Warycha M, Davies MA, et al.: Phosphorylated 4E-BP1 is associated with poor survival in melanoma. Clin Cancer Res 2009; 15: 2872-2878.
11. Benavente S, Verges R, Hermosilla E, et al.: Overexpression of phosphorylated 4E-BP1 predicts for tumor recurrence and reduced survival in cervical carcinoma treated with postoperative radiotherapy. Int J Radiat Oncol Biol Phys 2009; 75: 1316-1322.
12. Castellvi J, Garcia A, Ruiz-Marcellan C, et al.: Cell signaling in endometrial carcinoma: Phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis. Hum Pathol 2009; 40: 1418-1426.
13. Rojo F, Najera L, Lirola J, et al.: 4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis. Clin Cancer Res 2007; 13: 81-89. (Pubitemid 46121856)
14. Castellvi J, Garcia A, Rojo F, et al.: Phosphorylated 4E binding protein 1: A hallmark of cell signaling that correlates with survival in ovarian cancer. Cancer 2006; 107: 1801-1811. (Pubitemid 44582949)
15. Schmidt-Ullrich RK, Mikkelsen RB, Dent P, et al.: Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene 1997; 15: 1191-1197. (Pubitemid 27429622)
16. Berg D, Hipp S, Malinowsky K, et al.: Molecular profiling of signalling pathways in formalin-fixed and paraffin-embedded cancer tissues. Eur J Cancer 2010; 46: 47-55.
17. Chao YK, Yeh CJ, Chang HK, et al.: Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma. Ann Surg Oncol 2011; 18: 529-534.
18. Griffiths EA, Brummell Z, Gorthi G, et al.: The prognostic value of circumferential resection margin involvement in oesophageal malignancy. Eur J Surg Oncol 2006; 32: 413-419.
19. Khan OA, Fitzgerald JJ, Soomro I, et al.: Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer. Br J Cancer 2003; 88: 1549-1552. (Pubitemid 36713780)
20. Mariette C, Balon JM, Piessen G, et al.: Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer 2003; 97: 1616-1623. (Pubitemid 36350704)
21. Nakagawa S, Kanda T, Kosugi S, et al.: Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg 2004; 198: 205-211. (Pubitemid 38175235)